These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7725926)

  • 1. In vitro biopharmaceutical investigation of antacid activity in standard dissolution test apparatus.
    Plachy J; Antal I; Rácz I; Kulcsár-Molnár Z; Muskáth Z
    Acta Pharm Hung; 1995 Jan; 65(1):23-6. PubMed ID: 7725926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
    Vatier J; Ramdani A; Vitré MT; Mignon M
    Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
    Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
    Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro acid reactivity of three commercial antacid tablets.
    Spivey RJ; Goodhart FW
    Am J Hosp Pharm; 1979 May; 36(5):660-3. PubMed ID: 36756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.
    Hem SL; White JL; Buehler JD; Luber JR; Grim WM; Lipka EA
    Am J Hosp Pharm; 1982 Nov; 39(11):1925-30. PubMed ID: 7148862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antacid action of the aluminum cation: comparison of the in vitro effect of hydroxide and phosphate in open and closed systems].
    Vatier J; Lionnet F; Vitre MT
    Gastroenterol Clin Biol; 1987 Nov; 11(11):758-63. PubMed ID: 3428519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antacids--gel or tablet. A randomized, double-blind, placebo-controlled study].
    Schulthess HK; Häcki WH
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1016-9. PubMed ID: 4048899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS; Sun P; Yu HY
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of antacid value of magnesium-aluminium trisilicate dihydrate tablets.
    Jovanović M; Todorović G; Djurić Z; Bulajić V
    Pharmazie; 1985 Nov; 40(11):807. PubMed ID: 4095135
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of antacid tablets and liquid in fasting and fed men and women.
    Thomson AB; Pinchbeck B; Kirdeikis J; Kirdeikis P; Zuk L; Brunet MK; Jurima-Romet M; Murray PE
    Clin Ther; 1988; 10(2):158-68. PubMed ID: 3273863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of magaldrate antacid efficacy in the presence of some drugs and its effect on their dissolution rates: Part I.
    al Gohary OM
    Boll Chim Farm; 1996 Dec; 135(11):621-37. PubMed ID: 9066172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotelemetric comparison of two antacids using the Heidelberg capsule.
    Gómez Puch LM; Ríos Solans G; Muñoz y Fernandez JR
    Arzneimittelforschung; 1984; 34(10A):1378-80. PubMed ID: 6548925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of neutralizing properties of antacid preparations. Part 7. 27Al NMR studies of aluminum species formed during acid dissolution of some antacid preparations.
    Kokot Z
    Pharmazie; 1989 Dec; 44(12):828-30. PubMed ID: 2635320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approach for the in vitro evaluation of antacids.
    Vatier J; Vallot T; Vitre MT; Mignon M
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):175-9. PubMed ID: 2185759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the interaction between antacid and gastric mucosa using an "artificial stomach" model including gastric mucosa.
    Vatier JL; Gao Z; Fu-Cheng XM; Vitre MT; Levy DA; Cohen G; Mignon M
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1206-11. PubMed ID: 1469628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agent.
    McGraw BF; Hesterlee EJ; Lanza FL; Tesler MA
    Am J Gastroenterol; 1981 Nov; 76(5):412-5. PubMed ID: 6895973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations.
    Prieto R; Martinez-Tobed A; Fábregas JL; Beneyto JE
    Arzneimittelforschung; 1984; 34(10A):1360-4. PubMed ID: 6548920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of acid consuming capacity of artificial gastric juice for antacid tablets.
    Jovanović M; Samardzić Z; Djurić Z; Zajić L
    Pharmazie; 1988 Mar; 43(3):214-5. PubMed ID: 3380869
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the antacid properties of Gelox in a dynamic milieu using the artificial stomach apparatus].
    Vatier J; Vitre MT; Lionnet F; Mignon M
    Therapie; 1989; 44(1):43-8. PubMed ID: 2734720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of neutralization capacity of antacids in gastric juice].
    Halter F
    Z Gastroenterol; 1983 Mar; 21 Suppl():33-40. PubMed ID: 6858409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.